https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-332007-08-01 00:00:002007-08-01 00:00:00Dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Expert Opin Biol Ther 2007 Aug;7(8):1275-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Expert Opin Biol Ther 2007 Aug;7(8):1275-802007-08-01 00:00:002019-02-15 09:24:07Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-62007-08-01 00:00:002019-02-15 10:00:36Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int. J. Cancer 2007 Aug;121(3):467-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int. J. Cancer 2007 Aug;121(3):467-732007-08-01 00:00:002019-02-15 09:24:08Immunotherapy with dendritic cells for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-07-01 / Bull Cancer 2007 Jul;94(7 Suppl):F69-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-07-01 / Bull Cancer 2007 Jul;94(7 Suppl):F69-762007-07-01 00:00:002019-02-15 09:24:04[State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / Actas Urol Esp 2007 Jun;31(6):668-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / Actas Urol Esp 2007 Jun;31(6):668-792007-06-01 00:00:002019-02-15 09:24:03[Active immunotherapy of prostate cancer with a focus on dendritic cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Cancer Immunol. Immunother. 2007 Nov;56(11):1785-932007-05-01 00:00:002019-02-15 09:24:06TGF-beta insensitive dendritic cells: an efficient vaccine for murine prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-05-01 / Zhonghua Nan Ke Xue 2007 May;13(5):453-62007-05-01 00:00:002019-02-15 09:24:07[Changes of dendritic cells in prostate cancer and dendritic cell-based immunotherapy]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-10 / Prostate Cancer Prostatic Dis. 2007;10(3):224-362007-04-10 00:00:002019-02-15 09:24:05Immunology and immunotherapy approaches for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-04-01 / Prostate 2007 Apr;67(5):500-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-04-01 / Prostate 2007 Apr;67(5):500-82007-04-01 00:00:002019-02-15 09:24:10Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells–a pilot study
